A one-pot, three-component aminotriazine annulation onto 5-aminopyrazole-4-carbonitriles under microwave irradiation by Lim, Felicia Phei Lin et al.
NOTICE: this is the author’s version of a work that was 
accepted for publication in Tetrahedron Letters. Changes 
resulting from the publishing process, such as peer review, 
editing, corrections, structural formatting, and other quality 
control mechanisms may not be reflected in this document. 
Changes may have been made to this work since it was 
submitted for publication. A definitive version was subsequently 




A one-pot, three-component aminotriazine annulation onto 5-aminopyrazole-4-
carbonitriles under microwave irradiation




To appear in: Tetrahedron Letters
Received Date: 30 September 2014
Revised Date: 6 November 2014
Accepted Date: 3 December 2014
Please cite this article as: Lim, F.P.L., Luna, G., Dolzhenko, A.V., A one-pot, three-component aminotriazine
annulation onto 5-aminopyrazole-4-carbonitriles under microwave irradiation, Tetrahedron Letters (2014), doi:
http://dx.doi.org/10.1016/j.tetlet.2014.12.010
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting proof before it is published in its final form. Please note that during the production process




A one-pot, three-component aminotriazine 
annulation onto 5-aminopyrazole-4-
carbonitriles under microwave irradiation  
Felicia Phei Lin Lim, Giuseppe Luna, Anton V. Dolzhenko 
 
 






jo urn al  home pa ge:  w w w.els evi er .c om  
 
A one-pot, three-component aminotriazine annulation onto 5-aminopyrazole-4-
carbonitriles under microwave irradiation
§
 








School of Pharmacy, Curtin Health Innovation Research Institute, Curtin University, GPO Box U1987 Perth, Western Australia 6845, Australia 
b
 School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Selangor Darul Ehsan 47500, Malaysia 
 
——— 
§ Part 27 in the series ‘Fused heterocyclic systems with an s-triazine ring’, for part 26 see Ref. 1 
ARTIC LE  INFO  ABSTRAC T 
Article history: 
Received 
Received in revised form 
Accepted 
Available online 
A one-pot, three-component, microwave-assisted reaction of 5-aminopyrazole-4-carbonitriles, 
triethyl orthoformate and cyanamide afforded novel 7-arylamino-substituted 4-
aminopyrazolo[1,5-a][1,3,5]triazine-8-carbonitriles. The reaction proceeded in a chemo- and 
regioselective manner resulting in the successful amino-1,3,5-triazine annulation onto 5-
aminopyrazole-4-carbonitriles to give 4-aminopyrazolo[1,5-a][1,3,5]triazine-8-carbonitriles. The 
operational simplicity of the method and high purity of the products, which can be isolated via 
simple filtration, make this approach attractive for the preparation of a library of compounds for 
drug discovery processes. 











The development of methods for the synthesis of 
pyrazolo[1,5-a][1,3,5]triazines started more than half a century 
ago
2,3
 and has been particularly active recently.
4
 The main 
stimulus behind these investigations has been the identification of 
many biologically active compounds constructed on the basis of 
this heterocyclic system. The pyrazolo[1,5-a][1,3,5]triazine 
scaffold has become a very promising, from a medicinal 
chemistry perspective, 1,3,5-triazine-based purine isostere.
5
 
Amino substituents are common motifs in many interesting 
bioactive pyrazolo[1,5-a][1,3,5]triazines. Representative 
examples include the casein kinase II (CK2) inhibitor 1 (Figure 
1), which also demonstrated good anticancer properties.
6
 A cyano 
group at C-8 of 1 was also important for enzyme inhibition as 
changing it to a similar in size ethyl group led to an almost four-
order decrease in the inhibitory activity. The phosphodiesterase 
(PDE10) inhibitor 2, active in subnanomolar concentrations, 
demonstrated potential for the development of a new type of 
antipsychotic.
7
 Pexacerfont (3) is a potent antagonist of 
corticotrophin releasing factor (CRF1)
8
 undergoing clinical trials 
as a therapeutic agent for the treatment of anxiety-related alcohol 
craving and stress-induced food craving.9 Being strong 
cannabinoid receptor antagonists, compounds 4a,b have been 
proposed for the treatment of obesity.
10
 Additionally, 4a showed 
synergistic activity with levodopa in Parkinson’s disease 
therapy.11  
Recently, we developed a method for the synthesis of 4-
amino-substituted pyrazolo[1,5-a][1,3,5]triazin-2-amines, among 
which, 4-arylamino-substituted compounds demonstrated 
promising biological activity.
1
 Herein, we report a one-pot, three-
component synthesis of pyrazolo[1,5-a][1,3,5]triazines 
possessing an arylamino group located on C-7 of the heterocyclic 
system.  
Previously, we successfully achieved the aminotriazine 
annulation onto 3-amino-substituted 1,2,4-triazole-5-amines via 
the microwave-assisted reaction with triethyl orthoformate and 
cyanamide.
12
 Starting from 5-amino-3-arylaminopyrazole-4-
carbonitriles 5, we propose a similar approach for the synthesis of 
4-amino-7-arylaminopyrazolo[1,5-a][1,3,5]triazine-8-
carbonitriles 6 (Scheme 1, Pathway A). However, replacement of 
the N-4 atom in the triazole ring with a carbon atom bearing a 
cyano group might complicate the reaction due to the potental 
reactivity of the nitrile. 5-Aminopyrazole-4-carbonitriles have 
been known for a long time as useful building blocks for the 
synthesis of various heterocyclic compounds.
13
 Their reactions 
with triethyl orthoformate or its analogues, followed by treatment 
of the resulting intermediate with amines have been used for the 
construction of pyrimidine rings in the synthesis of bioactive 
pyrazolo[4,3-d]pyrimidines.
14
 Therefore, in the case of 
participation of the cyano group on the pyrazole ring in our three-
component reaction, we might expect at least one alternative 
transformation or side reaction, viz. the formation of 
pyrazolo[4,3-d]pyrimidines 7, which might further undergo the 
Dimroth rearrangement to give products 8 (Scheme 1, Pathway 
B).  
The starting 5-amino-3-arylaminopyrazole-4-carbonitriles (5) 
were prepared using a known method,
15
 exploiting the reaction of 
3,3-bis(methylsulfanyl)-2-cyanoacrylonitrile (9)
16
 with various 
anilines, followed by treatment of the resulting products 10 with 
hydrazine thus affording 5-amino-3-arylaminopyrazole-4-
carbonitriles 5 (Scheme 2).  
An attempt to carry out the reaction of 5a with triethyl 
orthoformate and cyanamide under microwave irradiation 
(150 °C, 25 min) led to the formation of a mixture of several 
products. The main component (75%) of this mixture was the 
desired product 6a, which could be isolated chromatographically. 
We were unable to improve the reaction outcome on 
manipulating the reaction time and temperature. Adding a base 
[diisopropylethylamine (DIPEA)] to the reaction mixture also did 
not increase the yield of 6a, but allowed isolation of this 
compound exclusively by simple filtration.  
The scope of this method was explored by the preparation of a 
library of 7-arylamino-substituted 4-aminopyrazolo[1,5-
a][1,3,5]triazine-8-carbonitriles 6 (Table 1).
17
 Compounds 6 were 
obtained in pure form under similar conditions. Electron-
withdrawing and electron-donating substituents on the arylamino 
moiety were equally well tolerated and the yields for all 
compounds within the series were comparable. 
The cyano group on the pyrazole ring remained intact as 
confirmed by a band at 2209-2228 cm
-1
 in the IR spectra 
(stretching vibrations) and resonances at 112.8-113.2 ppm in the 
13
C NMR spectra, therefore supporting the cyclization according 
to Pathway A (Scheme 1) and the formation of compounds 6.  
The low-field shifted singlet (8.14-8.19 ppm) and two broad 
signals at 8.33-8.48 ppm and 8.94-8.98 ppm in the 
1
H NMR 
spectra of compounds 6 were attributed to the ring proton (H-2) 
and the primary amino group protons at C-4 of the newly 
constructed aminotriazine ring. The lone pair of electrons of an 
amino group nitrogen on a 1,3,5-triazine ring possesses a high 
degree of delocalization resulting in the substantial p-character of 
the orbital and locking the amino group and its substituents in the 
plane of the heterocyclic ring.
18
 This phenomenon was 
manifested in hindered rotation around the C-N bond of the 
amino group and consequent splitting of the 
1
H NMR signals of 
this group in spectra of unsymmetrically substituted 1,3,5-
triazines. In the case of compounds 6, intramolecular hydrogen 
bonding with a nitrogen atom of the pyrazole ring could also 
contribute to the magnetic inequivalence of the two protons of 
the amino group at C-4 and therefore splitting of their signals in 
the 
1
H NMR spectra.  
  
  

























































Scheme 1. Three-component reaction of 5-amino-3-arylaminopyrazole-4-carbonitriles 5 with triethyl orthoformate and cyanamide. 































Table 1. Synthesis of 7-arylamino-substituted 4-aminopyrazolo[1,5-a][1,3,5]triazine-8-carbonitriles 6. 
 









































        
Recrystallization solvents: a MeCN, b DMF and H2O, 
c EtOH, d methoxyethanol, e pentanol.
In summary, we have successfully developed a one-pot, 
multicomponent, microwave-assisted synthesis of hitherto 
unknown 7-arylamino-substituted 4-aminopyrazolo[1,5-
a][1,3,5]triazine-8-carbonitriles 6. The developed approach 
utilizes selective annulations of the aminotriazine ring onto 5-
amino-3-arylaminopyrazole-4-carbonitriles 5. The good synthetic 

















































































































tool for the preparation of libraries of molecules for biological 
investigations.  
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